I listened. Informative? Yes. More potentials, negotiations, future trials, data coming, road shows, etc mentioned then before. Still sitting at 70 cents or so, once again dilution to keep afloat because King can't seem to get past negotiating and actually signing a deal. Over 400 patients have been treated using TNT. It's proven a safe delivery vehicle and King can't get one major license deal from it. What happened to our ocular? Tossed aside for a higher profile disease? Fine,license it out! $4000 in licensing fees last quarter is an embarrassment after 20+ years in the business. Why doesn't Tustin set a straight course a follow it? Breast cancer? Sure, let's go for it. Get approval on one form and the therapy can be used off label for others. We don't have to try to cure 10 different forms of cancer at one time nor do we have to find an antidote for every virus at one time. It looks good in the press releases and makes no sense when you're a cash strapped company. Remember the old ICQ days? We were supposed to be a multi national successful company by now according to the info going around then. How many years ago was that? 7? 8? 9?